BrunoSan Finance Intelligence · April 17, 2026

Finance Intelligence News

Every article includes an Intel Score breakdown — so you know exactly how strong each signal is and where it came from. Not editorial judgment. Signal mathematics.

🏦 RATE DECISION
1.000

ECB June Rate Hike Now Consensus as Geopolitical Shock Resets Inflation Forecasts

A Bloomberg survey of economists now shows consensus for a European Central Bank rate hike in June, pricing in a 25 basis point increase as the Iran conflict drives 2026 inflation forecasts sharply higher.
⚡ Score 1.000 🌐 1 source 📅 April 17, 2026 Read Analysis →
📊 EARNINGS
1.000

Netflix Q1 Geschäftszahlen Reveal Guidance Fracture: Stock Drops 7% Despite EPS Beat

Netflix beat Q1 2026 EPS estimates but issued Q2 profit guidance sharply below consensus, causing the stock to fall as markets re-price growth expectations based on a forecasted 150 basis point sequential decline in operating margin.
⚡ Score 1.000 🌐 1 source 📅 April 17, 2026 Read Analysis →
📊 EARNINGS
1.000

TSMC Q1 Earnings: 58% Profit Surge on AI Demand Confirms Advanced Node Dominance

TSMC reported a 58% YoY increase in Q1 net profit, beating consensus EPS estimates by 7.5% on persistent AI-driven demand for its advanced 3nm and 5nm process nodes, signaling sustained pricing power and a widening technology gap over competitors.
⚡ Score 1.000 🌐 1 source 📅 April 17, 2026 Read Analysis →
🚀 IPO
1.000

Aevex IPO Signals Rising Investor Demand for Military Drone Technology

Military drone manufacturer Aevex Corp. raised $320 million in its initial public offering, signaling robust investor appetite for defense technology amid escalating geopolitical tensions and a focus on autonomous systems.
⚡ Score 1.000 🌐 1 source 📅 April 17, 2026 Read Analysis →
🚀 IPO
1.000

Alamar Biosciences Prices Upsized $191 Million IPO, Signaling Renewed Appetite for Medical Device Sector

Medical device maker Alamar Biosciences raised $191 million in an upsized IPO priced at the top of its range, signaling robust institutional demand for high-science healthcare assets and potentially reopening the IPO window for the life sciences sector.
⚡ Score 1.000 🌐 1 source 📅 April 17, 2026 Read Analysis →